PTPI | Petros Pharmaceuticals, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.3501 - 0.3790
52 Week Range	0.2820 - 2.2700
Beta	2.07
Implied Volatility	456.99%
IV Rank	11.79%
Day's Volume	39,307
Average Volume	317,275
Shares Outstanding	9,606,680
Market Cap	3,636,128
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2020-12-02

Valuation
Profitability
Growth
Health
P/E Ratio	-0.06
Forward P/E Ratio	N/A
EPS	-6.25
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	21
Country	USA
Website	PTPI

Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including erectile dysfunction, peyronie's disease, hormone health and substance use disorders. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Prescription Medications segment. The Prescription Medications segment consists primarily of operations related to Stendra, which is sold generally in the United States, and H100 for the treatment of Peyronie's disease.

PTPI's peers: AKAN, ALIM, AYTU, BFRI, CPHI, CPIX, CYTH, EFOI, YCBD, COSM, EVOK, EYEG, FLGC, GHSI, LOGC, ORGO, SBFM, SNOA, TKNO, AGRX, PRFX, MNK, LFCR, LSDI, ADMP, HCANF, SXTC, GSAC, SHPH, RDHL, SIGA, TXMD, BGXX

*Chart delayed

Analyzing fundamentals for PTPI we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see PTPI Fundamentals page.

Watching at PTPI technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on PTPI Technicals page.